Treating Pancreatic Cancer with Cysteinase: A Potential New Approach
mohamed_hassan / Pixabay

Treating Pancreatic Cancer with Cysteinase: A Potential New Approach

According to a news release, researchers have found that cysteinase, a compound designed to treat a rare kidney stone disease, may also be effective in treating patients with pancreatic cancer.…

Continue Reading Treating Pancreatic Cancer with Cysteinase: A Potential New Approach
Questions for COVID-19: Should Cancer Patients Attend Appointments?
Photo by National Cancer Institute on Unsplash

Questions for COVID-19: Should Cancer Patients Attend Appointments?

  In a period of unprecedented changes, it is understandable that people may question what their lives may look like moving forward. COVID-19 has now spread to 196 countries and…

Continue Reading Questions for COVID-19: Should Cancer Patients Attend Appointments?
ICYMI: PharmaCyte Biotech’s New Weapon Against Pancreatic Cancer: Cell-in-a-Box® 
source: pixabay.com

ICYMI: PharmaCyte Biotech’s New Weapon Against Pancreatic Cancer: Cell-in-a-Box® 

  Cell-in-a-Box, the name of one of Biotech’s new products is just as intriguing as the drug itself. A recent article in NewsFile characterizes the product as having the potential…

Continue Reading ICYMI: PharmaCyte Biotech’s New Weapon Against Pancreatic Cancer: Cell-in-a-Box® 
Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?
source: pixabay.com

Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?

According to a story from Newsfile, the biotechnology company PharmaCyte is beginning to turn heads with the potential of its proprietary Cell-in-a-Box technology that has the potential to greatly improve…

Continue Reading Can PharmaCyte’s “Cell-in-a-Box” be a Breakthrough for Pancreatic Cancer?
Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
source: pixabay.com

Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“

  The ASCO Post recently reported findings of high response rates and improved survival from the combination of platinum-based cisplatin and gemcitabine (chemotherapy) in BRCA/PALB2 mutation positive pancreatic ductal adenocarcinoma. The goal…

Continue Reading Pancreatic Cancer: Researchers are Calling Patients’ Response to this Treatment “Unprecedented“
2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza
source: pixabay.com

2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza

  According to an article in BioSpace, the FDA recently approved the PARP inhibitor Lynparza that was developed by Merck and AstraZeneca to be used as maintenance therapy for pancreatic…

Continue Reading 2020 Brings Hope to Patients with Pancreatic Cancer Thanks to Newly Approved Lynparza
PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments
https://pixabay.com/en/notebook-work-girl-computer-woman-2386034/

PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments

According to a press release from Mateon Therapeutics, Mateon's recent merger agreement with PointR Data establishes plans to combine the use of artificial intelligence and data collection for the development…

Continue Reading PointR Data Merges into Mateon Therapeutics — Company Will Focus on Using Data Analysis and AI to Develop New Treatments
Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation
source: pixabay.com

Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation

According to a story from BioSpace, the biopharmaceutical company CrystalGenomics, Inc. recently announced that the US Food and Drug Administration (FDA) has granted the company's investigational drug candidate CG-745 Orphan…

Continue Reading Experimental Treatment for Pancreatic Cancer has Earned Orphan Drug Designation
Experimental Combination Treatment Offers Improved Survival in Pancreatic Cancer
Republica / Pixabay

Experimental Combination Treatment Offers Improved Survival in Pancreatic Cancer

According to a story from Medpage Today, a recent, small scale, early study of patients with local but advanced pancreatic cancer revealed that an experimental combination treatment comprised of chemoradiation…

Continue Reading Experimental Combination Treatment Offers Improved Survival in Pancreatic Cancer
Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
mohamed_hassan / Pixabay

Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia

According to a publication from EurekAlert, researchers from the University of Oklahoma College of Medicine (OUCM) recently published a study in the journal Gastroenterology suggesting how cachexia is triggered in…

Continue Reading Scientists Identify Possible Link Between Pancreatic Cancer and Muscle Wasting Condition Cachexia
Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
stevepb / Pixabay

Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers

According to a publication from the Arizona BioIndustry Association, Dr. Rachna Shroff and a team of researchers from the Arizona Cancer Center are studying the use of nab-paclitaxel (a pancreatic…

Continue Reading Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
mohamed_hassan / Pixabay

Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

According to a story from BioPortfolio, AstraZeneca and Merck have recently announced the results from a phase 3 clinical trial testing olaparib (marketed as LYNPARZA®) as a treatment for BRCA…

Continue Reading Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
New Collaboration Will Test Live Biotherapeutics Against Different Cancers
geralt / Pixabay

New Collaboration Will Test Live Biotherapeutics Against Different Cancers

According to a story from finanznachrichten.de, the biotherapeutics company 4D pharma has recently announced a research partnership with the MD Anderson Cancer Center at the University of Texas. The goal of…

Continue Reading New Collaboration Will Test Live Biotherapeutics Against Different Cancers

CRISPR Uncovers New Gene Fusion as Novel Drug Target for Brain, Ovarian and other Cancers

  CRISPR-Cas9, the genome editing tool, has caused quite a stir in the scientific community. According to a recent article in Science Daily, with results published in Nature Communications, CRISPR has…

Continue Reading CRISPR Uncovers New Gene Fusion as Novel Drug Target for Brain, Ovarian and other Cancers
Experimental Combination Treatment for Pancreatic Cancer Enters Phase II Trial
jarmoluk / Pixabay

Experimental Combination Treatment for Pancreatic Cancer Enters Phase II Trial

According to a story from Financial Buzz, the drug developer Rafael Pharmaceuticals, Inc., recently announced that a Phase II clinical trial that will test the company's experimental drug CPI-613 in…

Continue Reading Experimental Combination Treatment for Pancreatic Cancer Enters Phase II Trial
Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?
qimono / Pixabay

Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

According to a story from globenewswire.com, the biopharmaceutical company Innovation Pharmaceuticals recently released a report in which recent studies and pre-clinical research has suggested that the company's experimental drug Kevetrin…

Continue Reading Could This Investigational Drug be a New Treatment Option for Acute Myeloid Leukemia?

Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment

For years FibroGen has been investigating a drug called pamrevlumab. They believe it could be an effective treatment for Duchenne muscular dystrophy (DMD), pancreatic cancer, and idiopathic pulmonary fibrosis (IPF).…

Continue Reading Orphan Drug Designation Granted for Potential Duchenne Muscular Dystrophy Treatment
Close Menu